# Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

> **NCT00003907** · PHASE2 · COMPLETED · sponsor: **Eastern Cooperative Oncology Group** · enrollment: 50 (actual)

## Conditions studied

- Liver Cancer
- Metastatic Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** doxorubicin
- **DRUG:** mitomycin
- **PROCEDURE:** embolization

## Key facts

- **NCT ID:** NCT00003907
- **Lead sponsor:** Eastern Cooperative Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12-15
- **Primary completion:** 2011-05
- **Final completion:** 2012-08
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003907, "Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00003907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*